Saud Sadiq is a Neurology physician affiliated with Tisch Hospital. OpenAlex indexes 184 publications with 4,423 citations (h-index 37); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
425 W 59th St
Suite 7c
New York, NY 100191104
Telephone
212-523-8070Registry record last updated 8 Jul 2007.
Clinical trials
- Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis
Sponsor: Tisch Multiple Sclerosis Research Center of New York
- Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis
Sponsor: Tisch Multiple Sclerosis Research Center of New York
- Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
Sponsor: Tisch Multiple Sclerosis Research Center of New York
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
55.6%Gabapentinoids10.4%Gabapentin70%Pregabalin25%Lyrica5%Part D<11 patientsPotassium Channel Blocker9.4%Dalfampridine Er91%Ampyra9%Part D<11 patients+ 16 more classes in this area
Musculoskeletal
13.5%gamma-Aminobutyric Acid-ergic Agonist11.1%Baclofen100%Part D≥68 patientsCentral alpha-2 Adrenergic Agonist2.4%Tizanidine Hcl100%Part D<11 patientsCancer & immunology
12.8%Interferon beta5.5%Avonex (4 Pack)70%Avonex Pen (4 Pack)30%Part D<11 patientsPyrimidine Synthesis Inhibitor2.6%Teriflunomide61%Aubagio39%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1995–2001 per NIH RePORTER. The latest:
- HSP60 ABNORMALITIES IN SCHIZOPHRENIA
St. Luke'S-Roosevelt Inst for Hlth Scis
FY2001$270,222R01MH057982 - HSP60 ABNORMALITIES IN SCHIZOPHRENIA
St. Luke'S-Roosevelt Inst for Hlth Scis
FY2000$262,392R01MH057982
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mesenchymal stem cell-derived neural progenitors in progressive MS
Neurology Neuroimmunology & Neuroinflammation
2020
Similar KOLs
Other experts from the same institution or the same specialty.
James Ferrara, MD
Tisch Hospital
Dmitriy Zamarin, MD, PhD
Tisch Hospital
Paula Klein, MD
Tisch Hospital
Suchitra Sundaram, MD
Tisch Hospital
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”